Investor List:

Top Medical Devices Series A Investors in LatAm (Latin America) (20)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Medical Devices investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Pablo Fernandez, Managing Director
Pablo Fernandez
Managing Director
Sweet spot: $1M
Range: $500K - $1.5M
Investors in Brazil, Investors in Santiago (Chile), Investors in United States, Investors in Buenos Aires (Argentina), Investors in Colombia, Investors in Mexico (Mexico)
Investors in Medical Devices (Seed), Investors in AgTech (Series A), Investors in SMB Software (Seed), Investors in Food and Beverage (Seed), Investors in AgTech (Seed), Investors in IoT (Seed), Investors in Food and Beverage (Series A), Investors in BioTech (Seed), Investors in Medical Devices (Series A), Investors in IoT (Series A), Investors in SMB Software (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in AI (Seed), Investors in Investors who invested in female founders (Other Lists), Investors in AI (Series A), Investors in Investors who invested in diverse founders (Other Lists), Investors in Medical Devices (Pre-seed), Investors in AgTech (Pre-seed), Investors in Food and Beverage (Pre-seed), Investors in IoT (Pre-seed), Investors in SMB Software (Pre-seed), Investors in Health IT (Pre-seed), Investors in BioTech (Pre-seed), Investors in AI (Pre-seed), Investors in SaaS (Pre-seed), Investors in FinTech (Pre-seed), Investors in AgTech (Seed), Investors in AgTech (Series A), Investors in AI (Pre-seed), Investors in AgTech (Pre-seed), Investors in IoT (Seed), Investors in FinTech (Series A), Investors in Health IT (Pre-seed), Investors in Health IT (Series A), Investors in AI (Seed), Investors in Food and Beverage (Series A), Investors in SMB Software (Series A), Investors in BioTech (Series A), Investors in Medical Devices (Seed), Investors in AI (Series A), Investors in Health IT (Seed), Investors in SMB Software (Pre-seed), Investors in IoT (Pre-seed), Investors in FinTech (Seed), Investors in FinTech (Pre-seed), Investors in IoT (Series A), Investors in SMB Software (Seed), Investors in SaaS (Series A), Investors in SaaS (Seed), Investors in SaaS (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Food and Beverage (Pre-seed), Investors in Food and Beverage (Seed), Investors in BioTech (Pre-seed), Investors in LatAm (Latin America) (Other Lists), Investors in SaaS (Series A), Investors in Health IT (Seed), Investors in FinTech (Series A), Investors in FinTech (Seed), Investors in SaaS (Seed)
Photo of Juergen Wassmann, General Partner at Yaya Capital
Juergen Wassmann
Yaya Capital·General Partner
Sweet spot: $2.5M
Range: $100K - $5.0M
Investors in Brazil
Investors in Medical Devices (Seed), Investors in Web3/Blockchain (Series B), Investors in Consumer Health (Series B), Investors in Web3/Crypto (Series B), Investors in BioTech (Series B), Investors in Cloud Infrastructure (Series B), Investors in Cloud Infrastructure (Series A), Investors in Consumer Health (Series A), Investors in Cloud Infrastructure (Seed), Investors in Web3/Blockchain (Seed), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Web3/Blockchain (Series A), Investors in Consumer Health (Seed), Investors in Web3/Crypto (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series B), Investors in Web3/Crypto (Seed), Investors in Health & Hospital Services (Series A), Investors in Raleigh-Durham / Southeast US (Other Lists), Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series A), Investors in Health IT (Series A), Investors in Health IT (Series B), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Medical Devices (Seed), Investors in BioTech (Series B), Investors in Diagnostics (Series B), Investors in Cloud Infrastructure (Seed), Investors in Health IT (Seed), Investors in Cloud Infrastructure (Series B), Investors in Health & Hospital Services (Seed), Investors in Web3/Crypto (Seed), Investors in Cloud Infrastructure (Series A), Investors in Web3/Crypto (Series B), Investors in Consumer Health (Seed), Investors in Consumer Health (Series B), Investors in Diagnostics (Series A), Investors in Web3/Blockchain (Series B), Investors in Web3/Blockchain (Series A), Investors in Medical Devices (Series A), Investors in Web3/Blockchain (Seed), Investors in BioTech (Seed), Investors in Medical Devices (Series B), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Series A), Investors in Web3/Crypto (Series A), Investors in Digital Health (Series B), Investors in Diagnostics (Seed), Investors in LatAm (Latin America) (Other Lists), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Photo of Ignacio Peña, Managing Partner at AIR Capital
Ignacio Peña
AIR Capital·Managing Partner
Sweet spot: $200K
Range: $50K - $1.5M
Investors in Israel, Investors in United States, Investors in LatAm (Latin America)
Investors in EnergyTech (Seed), Investors in Medical Devices (Seed), Investors in Robotics (Pre-seed), Investors in Medical Devices (Series A), Investors in Digital Health (Seed), Investors in Robotics (Seed), Investors in Medical Devices (Series A), Investors in Robotics (Series A), Investors in Digital Health (Series A), Investors in DeepTech (Seed), Investors in BioTech (Seed), Investors in EnergyTech (Series A), Investors in Digital Health (Seed), Investors in AI (Pre-seed), Investors in Robotics (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Space (Seed), Investors in EnergyTech (Series A), Investors in Space (Series A), Investors in EnergyTech (Pre-seed), Investors in AI (Series A), Investors in Space (Seed), Investors in EnergyTech (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Space (Series A), Investors in Medical Devices (Series A), Investors in BioTech (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Robotics (Series A), Investors in BioTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in Israel (Other Lists), Investors in BioTech (Series A), Investors in AI (Series A), Investors in Investors who were founders (Other Lists), Investors in EnergyTech (Seed), Investors in BioTech (Series A), Investors in Medical Devices (Seed), Investors in AI (Seed), Investors in BioTech (Seed), Investors in AI (Seed), Investors in Medical Devices (Seed), Investors in Robotics (Seed), Investors in Space (Seed), Investors in AI (Series A), Investors in EnergyTech (Pre-seed), Investors in DeepTech (Series A), Investors in Space (Series A), Investors in DeepTech (Seed), Investors in Space (Pre-seed), Investors in DeepTech (Seed), Investors in Digital Health (Seed), Investors in DeepTech (Series A), Investors in Digital Health (Pre-seed), Investors in Robotics (Series A), Investors in Digital Health (Series A), Investors in Robotics (Pre-seed), Investors in AI (Seed), Investors in Robotics (Seed), Investors in DeepTech (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Space (Pre-seed), Investors in AI (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Space (Pre-seed), Investors in EnergyTech (Series A), Investors in Digital Health (Pre-seed), Investors in BioTech (Seed), Investors in DeepTech (Series A), Investors in AI (Pre-seed), Investors in EnergyTech (Seed), Investors in LatAm (Latin America) (Other Lists)
Photo of Ricardo Salomão, General Partner at Green Rock
Ricardo Salomão
Green Rock·General Partner
Sweet spot: $1.5M
Range: $500K - $3.0M
Investors in Sao Paulo (Brazil)
Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Series A), Investors in BioTech (Seed), Investors in Medical Devices (Series A), Investors in Consumer Health (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in Investors who invested in female founders (Other Lists), Investors in Health & Hospital Services (Series A), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Seed), Investors in Wellness & Fitness (Seed), Investors in Wellness & Fitness (Series A), Investors in Medical Devices (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Wellness & Fitness (Pre-seed), Investors in Health IT (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Digital Health (Series A), Investors in Health IT (Pre-seed), Investors in Health IT (Series A), Investors in Therapeutics (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Pre-seed), Investors in Consumer Health (Series A), Investors in Medical Devices (Seed), Investors in Therapeutics (Series A), Investors in Drug Delivery (Seed), Investors in Health IT (Seed), Investors in Pharmaceuticals (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Seed), Investors in Medical Devices (Pre-seed), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Consumer Health (Pre-seed), Investors in Wellness & Fitness (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Series A), Investors in Drug Delivery (Pre-seed), Investors in Wellness & Fitness (Pre-seed), Investors in Drug Delivery (Series A), Investors in Therapeutics (Series A), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Wellness & Fitness (Series A), Investors in Therapeutics (Pre-seed), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in Drug Delivery (Series B), Investors in Wellness & Fitness (Series B), Investors in Pharmaceuticals (Series B), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Digital Health (Series B), Investors in Wellness & Fitness (Series B), Investors in Therapeutics (Series B), Investors in Health IT (Series B), Investors in Pharmaceuticals (Series B), Investors in Consumer Health (Series B), Investors in Medical Devices (Series B), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Drug Delivery (Series B), Investors in Therapeutics (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B)
Photo of Marcus Pratini de Moraes, Managing Partner at Yaya Capital
Marcus Pratini de Moraes
Yaya Capital·Managing Partner
Sweet spot: $2.5M
Range: $100K - $5.0M
Investors in Brazil
Investors in Web3/Blockchain (Series B), Investors in Medical Devices (Seed), Investors in Consumer Health (Series B), Investors in Web3/Crypto (Series B), Investors in BioTech (Series B), Investors in Cloud Infrastructure (Series B), Investors in Cloud Infrastructure (Series A), Investors in Consumer Health (Series A), Investors in Cloud Infrastructure (Seed), Investors in Web3/Blockchain (Seed), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Web3/Blockchain (Series A), Investors in Consumer Health (Seed), Investors in Web3/Crypto (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series B), Investors in Web3/Crypto (Seed), Investors in Health & Hospital Services (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series A), Investors in Health IT (Series A), Investors in Health IT (Series B), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Medical Devices (Seed), Investors in BioTech (Series B), Investors in Diagnostics (Series B), Investors in Cloud Infrastructure (Seed), Investors in Health IT (Seed), Investors in Cloud Infrastructure (Series B), Investors in Health & Hospital Services (Seed), Investors in Web3/Crypto (Seed), Investors in Cloud Infrastructure (Series A), Investors in Web3/Crypto (Series B), Investors in Consumer Health (Seed), Investors in Consumer Health (Series B), Investors in Diagnostics (Series A), Investors in Web3/Blockchain (Series B), Investors in Web3/Blockchain (Series A), Investors in Medical Devices (Series A), Investors in Web3/Blockchain (Seed), Investors in BioTech (Seed), Investors in Medical Devices (Series B), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Series A), Investors in Web3/Crypto (Series A), Investors in Digital Health (Series B), Investors in Diagnostics (Seed), Investors in LatAm (Latin America) (Other Lists), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Photo of Mario Sergio Ribeiro, Partner at DNA Capital
Mario Sergio Ribeiro
DNA Capital·Partner
Sweet spot: $2.5M
Range: $100K - $5.0M
Investors in Sao Paulo (Brazil)
Investors in Medical Devices (Seed), Investors in Consumer Health (Series B), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Consumer Health (Series A), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Consumer Health (Seed), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series A), Investors in Health IT (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series B), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B), Investors in Health IT (Seed), Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Seed), Investors in Consumer Health (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Medical Devices (Series B), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Seed), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Photo of Adam Alves, Partner at DNA Capital
Adam Alves
DNA Capital·Partner
Sweet spot: $2.5M
Range: $100K - $5.0M
Investors in Sao Paulo (Brazil)
Investors in Medical Devices (Seed), Investors in Consumer Health (Series B), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Consumer Health (Series A), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Consumer Health (Seed), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series A), Investors in Health IT (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series B), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Medical Devices (Seed), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B), Investors in Health IT (Seed), Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Seed), Investors in Consumer Health (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Medical Devices (Series B), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Photo of Robert Séguin, Managing Partner at Westmount Capital
Robert Séguin
Westmount Capital·Managing Partner
Sweet spot: $150K
Range: $100K - $250K
Investors in Barcelona (Spain), Investors in Madrid (Spain), Investors in Paris (France), Investors in Peru, Investors in Geneva, Investors in Zurich (Switzerland), Investors in Rome (Italy), Investors in Milan (Italy), Investors in Bogota (Colombia), Investors in Medellin (Colombia), Investors in Amsterdam (Netherlands), Investors in Basel (Switzerland)
Get new data & insights delivered to your inbox